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Abstract 
Aim: To examine current incidence trends (1975–2012) of oral cavity (OCC), oropharyngeal 
(OPC) and laryngeal cancer in Scotland by socioeconomic status (SES). 
 
Methods: We included all diagnosed cases of OCC (C00.3-C00.9, C02-C06 excluding C2.4), 
OPC (C01, C2.4, C09-C10, C14) and laryngeal cancer (C32) on the Scottish Cancer Registry 
(1975–2012) and annual mid-term population estimates by age, sex, geographic region and SES 
indices (Carstairs 1991 and Scottish Index of Multiple Deprivation 2009). Age-standardized 
incidence rates were computed and adjusted Poisson regression rate-ratios (RR) compared 
subsites by age, sex, region, SES and year of diagnosis. 
 
Results: We found 28,217 individuals (19,755 males and 8462 females) diagnosed with head 
and neck cancer (HNC) over the study period. Between 1975 and 2012, relative to the least 
deprived areas, those living in the most deprived areas exhibited the highest RR (>double) of 
OCC, OPC and laryngeal cancer, and an almost dose-like response was observed between SES 
and HNC incidence. Between 2001 and 2012, this socioeconomic inequality tended to increase 
over time for OPC and laryngeal cancer but remained relatively unchanged for OCC. Incidence 
rates increased markedly for OPC, decreased for laryn-geal cancer and remained stable for OCC, 
particularly in the last decade. Males exhibited significantly higher RRs compared to females, 
and the peak age of incidence of OPC was slightly lower than the other subsites. 
 
Conclusion: Contrary to reports that OPC exhibits an inverse socioeconomic profile, Scotland 
country-level data show that those from the most deprived areas consistently have the highest 
rates of head and neck cancers. 
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Introduction 
Cancers of the oral cavity and oropharynx are amongst the most common cancers worldwide, 
with approximately 442,760 incident cases and 241,418 deaths reported in 2012 [1]. Collectively, 
these head and neck cancers are the seventh most common in terms of incidence and the ninth 
most common cause of death in the world [2].  
Global incidence rates of oropharyngeal cancer (OPC) are rising, particularly in economically 
developed countries such as Canada, United States, Japan, Switzerland, Australia, England and 
parts of Eastern Europe [3-7]. Rates of oral cavity cancer (OCC) are also rising among men and 
women in some European countries, stabilising in certain Asian countries and decreasing in 
Canada and USA [4, 8]. 
Tobacco and alcohol consumption are the dominant risk factors for OCC [9], and are also a part 
of the aetiology for OPC along with human papillomavirus (HPV) infections [10]. Hashibe and 
Sturgis have suggested that this changing profile of head and neck cancer incidence can be 
explained by “controlling a tobacco epidemic while a human papillomavirus epidemic emerges” 
[11]. Moreover, the clinical perspective, recorded in a US case-series, is that the 
sociodemographic profile of head and neck cancer patients is also changing, with increasing 
numbers of patients, particularly with OPC diagnosis, having a younger, more socioeconomically 
affluent profile [12]. 
The most recent detailed analysis of incidence trends of oral cancer in Scotland examined rates 
between 1990 and 1999, and found that Scotland had the highest rates of oral cancer in the UK 
and also exhibited the greatest lifetime risk of developing oral cancer [13]. Overall, rates 
increased in both males and females between 1990 and 1999. However, this study combined 
both OCC and OPC into a single oral cancer definition in the trends analysis, reflecting the 
thinking at the time that these sites had a common aetiology.  
The aim of this study was to examine the incidence burden and trends of OCC, OPC and 
laryngeal cancer in Scotland between 1975 and 2012 by key sociodemographic determinants 
available in the Scottish Cancer Registry: age, sex, area-based socioeconomic deprivation 
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indices, geographic region and year of diagnosis. Additionally, we aimed to compute future 
projected rates up to 2025 by the same determinants.  
Methods 
We collated data on all diagnosed cases of OPC, OCC and laryngeal cancer registered at the 
Scottish Cancer Registry between 1975 and 2012. Subsites were defined using three-digit ICD-
10 codes and were anatomically classified into: oropharynx OPC (base of tongue C01, lingual 
tonsil C2.4, tonsil C09, oropharynx C10, pharynx C14); oral cavity OCC (inner lip C00.3-C00.9, 
other and unspecified parts of tongue C02, gum C03, floor of mouth C04, palate C05, other and 
unspecified parts of mouth C06); and larynx (C32). Additionally, all head and neck cancer (HNC) 
grouping included all of these subsites along with outer lip (C00.0-C00.2), salivary glands (C07, 
C08), nasopharynx (C11), piriform sinus (C12), hypopharynx (C13), and other and ill-defined 
sites of the lip, oral cavity and pharynx (C14). Age was grouped into five-year categories for the 
purpose of analysis. Based on NHS health board boundaries, the geographic regions were 
grouped into North (Grampian, Highland, Islands), East (Borders, Fife, Forth Valley, Lothian, 
Tayside), and West (Ayrshire and Arran, Dumfries & Galloway, Greater Glasgow & Clyde, 
Lanarkshire). Socioeconomic status was primarily measured using the area-based Carstairs 
Deprivation index grouped into deciles (14). This index is measured at the postcode sector level 
and takes four population census variables into account: male unemployment, households with 
no car, overcrowded households and the percentage of people in social classes IV and V. We 
also collated annual mid-year population estimates by age, sex, deprivation indices and 
geographic regions. Additional analysis was performed on cases diagnosed between 2000 and 
2012 in order to utilize the more recently developed small area-based socioeconomic index, the 
Scottish Index of Multiple Deprivation (SIMD 2009) (15). This index is calculated taking seven 
domains of deprivation into consideration: income, employment, education, housing, health, 
crime and geographical access. It is measured at the data zone (neighbourhood) level (n=x of 
pop), which is a smaller population than the Carstairs postcode sector (n=x pop) (15).  
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Statistical Analysis 
Age-standardized incidence rates and projected rates up to 2025 were calculated for all subsites 
by age, sex, deprivation, region, and year of diagnosis. Direct standardization was carried out 
using the European Standard population, to account for changes in the age composition of the 
population [16]. Adjusted Poisson regression rate-ratios were used to compare the subsites by 
age, sex, socioeconomic deprivation, geographical region and year of diagnosis. All statistical 
analyses were performed using SAS V9.3.   
Results  
Our study comprised of 28,217 individuals, of which 19,755 (70.2%) were males and 8,462 
(29.9%) were females. The mean age was 63.8 years (standard deviation: ± 12.3 years). The 
age-standardised incidence rates of cancer per 100,000 individuals and the fully adjusted 
Poisson regression rate-ratios (RR) by sociodemographic characteristics are presented in Tables 
1 and 2, respectively.  
Peak incidence of OPC was observed in the 61-65 age-group, while that of OCC and laryngeal 
cancer were in the 71-75 age-group (Table 1). In the model, the 41-45 age-group was chosen as 
the reference category as the incidence rates in younger groups were very small, suggesting that 
this was a disease that primarily affected the older population. Regression analysis showed that 
the rates of OPC were more than double in the 61-65 age-group (RR 2.34, 95% CI 2.08-2.63) 
compared to the reference category (41-45 age-group), and this was statistically significant 
(Table 2). The highest rate-ratios for OCC (RR 3.54, 95% CI 3.20-3.91) and laryngeal cancer 
(RR 4.74, 95% CI 4.30-5.23) were observed in the 76-80 and 71-75 age-groups, respectively, 
relative to the reference group (Table 2).  
Males were found to exhibit higher incidence rates than females in all subsites (Table 1). The 
rates in males were more than three times that of females (RR 3.10, 95% CI 2.90-3.30) for OPC, 
more than double for OCC (RR 2.11, 95% CI 2.02-2.20), and 4.77 times for  laryngeal cancer 
(RR 4.77, 95% CI 4.54-5.01) (Table 2).  
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No major differences in incidence burden were observed between the different geographic 
regions, with rate-ratios of the North, East and West health board regions being similar 
irrespective of subsite.   
The rate-ratios of OPC (RR 2.49, 95%CI 2.18-2.86) and OCC (RR 2.40, 95%CI 2.18-2.65)  in the 
most deprived (Carstairs 1) areas were significantly higher than those in the least deprived 
(Carstairs 10) areas across all subsites. Moreover, a dose-like effect was observed, with rates of 
cancer increasing with increasing deprivation (Table 2). This socioeconomic inequality persisted 
in the analysis of cases diagnosed between 2001 and 2012 using SIMD. Moreover, the 
socioeconomic gap widened in OPC (RR 3.33, 95% CI 2.72-4.07) and laryngeal cancer (RR 4.98; 
95% CI 4.15-5.97), but remained relatively unchanged for OCC (RR 2.69; 95% CI 2.31-3.13) 
over the past decade (Figure 2).   
Incidence rates of OPC increased by 245% between 1975 and 2012 (RR 3.45, 95% CI 2.66-
4.48), while rates of OCC showed a smaller increase of 86% over the same period (RR 1.86, 95% 
CI 1.53-2.26). Both of these increases were statistically significant (Figure 1). Rates of laryngeal 
cancer increased by only 12%, but this was not statistically significant (RR 1.12, 95% CI 0.92-
1.35). Between 2001 and 2012, incidence rates of OPC increased by 85% (RR 1.85, 95% CI 
1.53-2.25), rates of OCC remained relatively stable (RR 1.10, 95% CI 0.94-1.28), and rates of 
laryngeal cancer decreased by 23% (RR 0.77, 95% CI 0.65-0.90).  
Incidence projections up to 2025 show an expected continuation with increases in the rates of 
HNC, and this appears to be largely driven by a rapid increase in the rates of OPC. Moreover, 
OPC is expected to overtake the rates of OCC, which continue to remain relatively stable. Rates 
of laryngeal cancer were expected to decrease over the projection period (Figure 3).  
Discussion 
By 2012, the incidence rates of OPC had overtaken those of laryngeal cancer and were nearly 
on par with OCC incidence.  Moreover, by 2025 the projected incidence rates of OPC are 
expected to continue to rise rapidly and bypass rates of OCC which are expected to continue to 
remain relatively stable. Rates of laryngeal cancer are expected to decrease over the same time 
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period. The peak age of incidence of OPC was slightly younger (5-10 years) than for the other 
subsites, and rates were consistently higher in males compared to females irrespective of subsite. 
Our study was the first national descriptive epidemiology study to examine trends in HNC by SES. 
We observed socioeconomic inequality in incidence across all subsites, with the most deprived 
areas consistently exhibiting the highest rates of head and neck cancer relative to the least 
deprived areas. 
An age-period-cohort analysis of global data reported similar overall trends of increasing OPC 
and stabilising OCC [4]. In England, a detailed cancer registry analysis reported that the 
incidence rates of head and neck cancer (HNC) increased by 58.9% in the sixteen year study 
period, with the greatest increase in rates of OPC (average annual percentage change = +7.3% 
in males and +6.5% in females) [3]. Our results showed an increase of 32.13% in HNC rates in 
Scotland over the same time period (1995 to 2011), and this was largely driven by a rapid 
increase in the rates of OPC. HNC rates were also expected to continue to rise up to 2025 in 
England, with the largest increase being observed in rates of OPC, while OCC was predicted to 
stabilize in men and continue to increase in women. Moreover, rates of OPC were seen to be 
higher in younger individuals (< 60 years) in England [3]. Our projection estimates showed a 
similar increase in rates of HNC, driven largely by a rapid rise in rates of OPC, in Scotland. 
Moreover, the peak incidence of OPC in Scotland was observed in the 61-65 age-group, and this 
was also in agreement with previous studies. It has been suggested that this plateauing in rates 
of OCC may be a result of the decreasing global rates of smoking observed in the recent past, 
and the increase in rates of OPC possibly reflect the changes in sexual behaviours among recent 
birth cohorts, which in turn increases risk of exposure to oral HPV infection [3, 4]. 
We also observed higher rates amongst men, which was in agreement with another retrospective 
analysis conducted by Gillison et al in USA [17]. This difference in incidence rates could be 
explained in part by the greater prevalence of HPV among men compared to women [5, 11, 18]. 
However, in contrast to a previous small clinical series [12], we found that socioeconomic 
inequalities in rates of cancer persisted irrespective of cancer subsite in Scotland, with the most 
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deprived areas of the country consistently showing the highest rate-ratios relative to the least 
deprived areas. Although previous studies have examined the trends of HNC and subsites in 
Scotland, they have combined OCC and OPC, which may have masked the differential rates by 
subsite [13].  
Geographic area-based deprivation indices result in all individuals living within a certain area 
being assigned the same score. Interpretation of these area-based measures is complex. When 
used as a surrogate individual measure, it may be inferred that all persons living in a certain 
socioeconomic area have the same individual socioeconomic status, and this has been 
described as an ‘ecological fallacy’ [19, 20]. However, the ecological interpretation can have 
some advantages in terms of indicating the social and physical environment or circumstances, 
for example, adequate access to health care services. Ideally, a combination of individual and 
area-based socioeconomic measures would be combined in a multi-level analysis to take 
account of individual and area effects.   
The strengths of this study are based on the high quality national data which provides a 
population representative cohort over several decades. The quality indicators for registration of 
head and neck cancer tumours at the Scottish Cancer Registry are high, with approximately 85% 
of cases being microscopically confirmed and less than 2% Death Certificate Only registrations 
[21, 22]. Moreover, several studies have provided evidence of the high, and constantly improving, 
case-ascertainment [23-25]. The limitations of this study include the lack of data on tumour HPV 
positivity, behavioural factors (e.g. tobacco and alcohol consumption), and individual measures 
of socioeconomic status [26]. Data on HPV and behaviours would have allowed estimation of the 
proportion of changes in incidence rates that could be attributed to various risk factors and 
socioeconomic determinants. This information may help provide a clearer picture of what is 
driving the changing trends of head and neck cancer.  
Conclusion 
In conclusion, this study shows the changing trends in the burden and determinants of HNC. 
OPC is an emerging public health problem, with rates dramatically increasing in Scotland. 
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Despite previous reports, the sociodemographic determinants of oropharyngeal cancer are not 
substantially different from other HNCs, particularly in relation to gender and SES profile 
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Figure 1: European age-standardised incidence rates (EASR) for each subsite over time from 
1975 to 2012.  (HNC: All head & neck cancer, OPC: Oropharyngeal cancer, OCC: Oral cavity 
cancer 
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Figure 2: Incidence rates for each subsite by Scottish Index of Multiple Deprivation (SIMD) 2009, 
where 1= most deprived and 10=least deprived (2001-2012). (HNC: All head & neck cancer, 
OPC: Oropharyngeal cancer, OCC: Oral cavity cancer) 
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Figure 3: Incidence rates per 100k persons between 2001-2012 (bold lines) and projected rates 
(dotted lines) up to 2025 for each subsite (HNC: All head & neck cancer, OPC : Oropharyngeal 
cancer, OCC: Oral cavity cancer) 
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Table 1: EASR per 100,000 person-years by age, sex, geographic region, deprivation (Carstairs 
1991), and year of diagnosis (1975-2012)  
 
 
 
  
 HNC OPC OCC Larynx 
 N Rate N Rate N Rate N Rate 
Age 
0-25 135 0.28 7 0.01 35 0.07 5 0.01 
26-30 87 0.94 2 0.02 29 0.31 5 0.05 
31-35 145 1.54 9 0.10 44 0.47 16 0.17 
36-40 294 3.46 36 0.42 79 0.93 67 0.79 
41-45 537 6.39 80 0.96 177 2.11 150 1.79 
46-50 1185 15.13 179 2.32 408 5.27 402 5.19 
51-55 1817 22.80 261 3.38 603 7.79 674 8.67 
56-60 2484 32.17 349 4.72 756 10.19 1001 13.41 
61-65 2648 38.64 348 5.37 803 12.29 1091 16.62 
66-70 2736 41.80 328 5.26 866 13.84 1119 17.75 
71-75 2334 45.52 260 5.27 747 15.11 935 18.79 
76-80 1656 44.71 175 4.81 609 16.66 572 15.65 
81-85+ 1015 30.61 109 3.30 421 12.75 293 8.88 
Sex 
Male 19755 20.67 3352 3.60 5851 6.28 7744 8.29 
Female 8462 8.41 1272 1.27 3467 3.46 2009 2.01 
Region 
North 9768 13.55 1547 2.18 3201 4.50 3375 4.74 
East 4431 14.56 786 2.59 1467 4.84 1286 4.24 
West 14018 14.95 2291 2.50 4650 5.06 5092 5.53 
Carstairs 
1 4254 21.53 682 3.51 1354 6.95 1644 8.42 
2 3499 17.40 534 2.77 1122 5.80 1337 6.89 
3 3059 15.44 490 2.53 983 5.07 1107 5.69 
4 3050 15.56 545 2.83 948 4.92 1090 5.65 
5 2676 13.63 431 2.23 893 4.61 901 4.64 
6 2717 14.00 426 2.22 939 4.90 927 4.83 
7 2483 12.68 426 2.20 855 4.41 766 3.95 
8 2453 12.62 402 2.09 848 4.41 785 4.08 
9 2154 11.06 364 1.88 736 3.81 656 3.39 
10 1872 9.63 324 1.68 640 3.31 540 2.79 
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Year  
1975 502 12.57 69 1.75 140 3.73 180 4.50 
1976 439 10.95 55 1.42 135 3.52 153 3.75 
1977 521 12.66 63 1.60 155 3.95 173 4.25 
1978 485 11.70 60 1.51 130 3.32 187 4.55 
1979 513 12.57 55 1.40 148 3.79 176 4.29 
1980 531 12.99 55 1.42 152 3.81 190 4.65 
1981 594 14.30 49 1.20 184 4.63 220 5.32 
1982 585 13.94 54 1.32 215 5.28 203 4.95 
1983 634 14.92 77 1.90 188 4.62 249 6.04 
1984 589 14.03 51 1.22 200 4.88 231 5.60 
1985 643 15.03 74 1.78 215 5.22 4.87 5.89 
1986 621 14.65 61 1.46 187 4.50 246 5.90 
1987 608 14.17 62 1.46 226 5.44 214 5.08 
1988 651 15.00 73 1.73 224 5.32 242 5.73 
1989 674 15.29 88 2.08 219 5.18 252 5.94 
1990 718 16.30 86 2.03 242 5.70 278 6.59 
1991 720 16.37 97 2.29 244 5.74 274 6.47 
1992 710 16.03 92 2.14 236 5.55 302 7.06 
1993 719 16.22 91 2.13 234 5.43 288 6.73 
1994 739 16.43 91 2.09 259 5.98 282 6.49 
1995 750 16.61 104 2.40 267 6.19 253 5.79 
1996 864 18.72 124 2.83 271 5.49 340 7.77 
1997 768 16.76 138 3.11 245 5.55 255 5.81 
1998 826 17.94 103 2.33 296 6.64 279 6.37 
1999 865 18.61 138 3.09 298 6.71 313 7.09 
2000 804 17.11 133 2.96 267 5.93 305 6.85 
2001 880 19.81 152 3.35 289 6.51 314 7.13 
2002 858 19.12 150 3.28 304 6.80 286 6.41 
2003 893 19.65 162 3.51 324 7.08 289 6.46 
2004 906 19.80 182 3.95 306 6.68 304 6.71 
2005 883 18.98 182 3.79 315 6.79 276 6.06 
2006 931 19.86 191 3.98 304 6.50 310 6.69 
2007 961 20.20 202 4.17 341 7.17 291 6.17 
2008 910 18.79 203 4.13 324 6.70 276 5.77 
2009 1029 20.97 266 5.25 339 6.97 281 5.83 
2010 1025 20.71 241 4.73 344 7.00 306 6.29 
2011 1016 20.32 253 4.93 328 6.56 288 5.86 
2012 1124 22.04 320 6.17 357 7.04 270 5.35 
         
EASR: European age standardized rates, HNC: Head & neck cancer; OPC: 
          cancer; OCC: Oral cavity cancer; N: Number of events 
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Table 2: Adjusted Poisson regression rate-ratios for subsites by age, sex, geographic region, deprivation (Carstairs 1991), 
and year of diagnosis (1975-2012) 
  
HNC OPC OCC LARYNX 
RR 95% CI p RR 95% CI    p RR 95% CI p RR 95% CI p 
Age 
0-25 0.02 0.02-
 
<.001 0.01 0.00-0.01 <.00
 
0.02 0.01-
 
<.001 0.00 0.00-
 
<.001 
26-30 0.07 0.05-
 
<.001 0.02 0.01-0.03 <.00
 
0.07 0.05-
 
<.001 0.02 0.01-
 
<.001 
31-35 0.10 0.09-
 
<.001 0.04 0.03-0.07 <.00
 
0.10 0.08-
 
<.001 0.04 0.02-
 
<.001 
36-40 0.24 0.21-
 
<.001 0.17 0.13-0.22 <.00
 
0.20 0.17-
 
<.001 0.17 0.13-
 
<.001 
41-45 0.46 0.43-
 
<.001 0.45 0.38-0.53 <.00
 
0.45 0.39-
 
<.001 0.37 0.32-
 
<.001 
46-50 
 
-   -   -   -   
51-55 1.62 1.53-
 
<.001 1.62 1.44-1.83 <.00
 
1.58 1.43-
 
<.001 1.82 1.64-
 
<.001 
56-60 2.38 2.25-
 
<.001 2.21 1.97-2.49 <.00
 
2.31 2.10-
 
<.001 3.02 2.74-
 
<.001 
61-65 2.79 2.65-
 
<.001 2.34 2.08-2.63 <.00
 
2.73 2.49-
 
<.001 3.73 3.39-
 
<.001 
66-70 3.06 2.90-
 
<.001 2.19 1.93-2.47 <.00
 
3.04 2.77-
 
<.001 4.29 3.90-
 
<.001 
71-75 3.39 3.21-
 
<.001 2.03 1.78-2.32 <.00
 
3.30 3.00-
 
<.001 4.74 4.30-
 
<.001 
76-80 3.44 3.24-
 
<.001 1.97 1.71-2.28 <.00
 
3.54 3.20-
 
<.001 4.32 3.89-
 
<.001 
81-85+ 2.36 2.20-
 
<.001 1.08 0.90-1.29 0.39
 
2.66 2.39-
 
<.001 2.56 2.26-
 
<.001 
Sex 
 Male 2.72 2.66-
 
<.001 3.10 2.90-3.30 <.00
 
  2.11 2.02-
 
<.001 4.77 4.54-
 
<.001 
Female 
(ref.) -   -   -   -   
Region 
North 
 
-   -   -   -   
East 0.85 0.82-
 
<.001 0.81 0.74-0.88 <.00
 
0.88 0.83-
 
<.001 1.01 0.95-
 
0.738 
West 0.81 0.78-
 
<.001 0.85 0.78-0.92 <.00
 
0.89 0.84-
 
<.001 0.98 0.92-
 
0.527 
Carstairs 1991 
1 2.59 2.45-
 
<.001 2.49 2.18-2.86 <.00
 
2.40 2.18-
 
<.001 3.34 3.02-
 
<.001 
2 1.83 1.72-
 
<.001 1.83 1.59-2.11 <.00
 
1.86 1.69-
 
<.001 2.50 2.26-
 
<.001 
3 1.66 1.57-
 
<.001 1.67 1.45-1.92 <.00
 
1.62 1.47-
 
<.001 2.07 1.87-
 
<.001 
4 1.66 1.57-
 
<.001 1.85 1.61-2.12 <.00
 
1.56 1.41-
 
<.001 2.06 1.86-
 
<.001 
5 1.47 1.38-
 
<.001 1.44 1.25-1.66 <.00
 
1.47 1.32-
 
<.001 1.71 1.54-
 
<.001 
6 1.42 1.34-
 
<.001 1.35 1.17-1.56 <.00
 
1.47 1.33-
 
<.001 1.70 1.53-
 
<.001 
7 1.30 1.22-
 
<.001 1.32 1.15-1.53 <.00
 
1.33 1.20-
 
<.001 1.39 1.24-
 
<.001 
8 1.26 1.19-
 
<.001 1.24 1.07-1.43 0.00
 
1.30 1.17-
 
<.001 1.40 1.26-
 
<.001 
9 1.12 1.05-
 
<.001 1.13 0.97-1.31 0.10
 
1.14 1.02-
 
0.019 1.19 1.06-
 
0.003 
10 (ref.) 
 
-   -   -   -   
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Year 
1975 (ref.) -   -   -   -   
1976 0.88 0.77-
 
0.049 0.79 0.56-1.13 0.20
 
0.96 0.76-
 
0.732 0.84 0.68-
 
0.118 
1977 1.02 0.91-
 
0.698 0.90 0.64-1.27 0.56
 
1.10 0.87-
 
0.426 0.95 0.77-
 
0.645 
1978 0.94 0.83-
 
0.355 0.86 0.61-1.22 0.40
 
0.92 0.72-
 
0.475 1.00 0.82-
 
0.972 
1979 1.01 0.89-
 
0.872 0.79 0.55-1.12 0.19
 
1.04 0.83-
 
0.736 0.96 0.78-
 
0.699 
1980 1.04 0.92-
 
0.507 0.79 0.55-1.12 0.18
 
1.06 0.84-
 
0.606 1.04 0.84-
 
0.736 
1981 1.15 1.02-
 
0.024 0.70 0.48-1.00 0.05
 
1.28 1.03-
 
0.027 1.19 0.97-
 
0.091 
1982 1.11 0.99-
 
0.080 0.77 0.54-1.09 0.14
 
1.49 1.20-
 
<.001 1.09 0.89-
 
0.427 
1983 1.18 1.05-
 
0.006 1.09 0.79-1.51 0.60
 
1.30 1.04-
 
0.020 1.31 1.08-
 
0.006 
1984 1.13 1.00-
 
0.052 0.72 0.50-1.03 0.07
 
1.37 1.10-
 
0.005 1.24 1.02-
 
0.035 
1985 1.19 1.06-
 
0.003 1.04 0.75-1.44 0.82
 
1.45 1.18-
 
<.001 1.29 1.06-
 
0.010 
1986 1.17 1.04-
 
0.007 0.85 0.60-1.20 0.36
 
1.27 1.02-
 
0.034 1.29 1.06-
 
0.010 
1987 1.14 1.01-
 
0.034 0.86 0.61-1.21 0.38
 
1.52 1.23-
 
<.001 1.11 0.91-
 
0.293 
1988 1.20 1.07-
 
0.002 1.01 0.73-1.40 0.95
 
1.50 1.21-
 
<.001 1.25 1.03-
 
0.024 
1989 1.22 1.08-
 
<.001 1.21 0.88-1.66 0.23
 
1.45 1.17-
 
<.001 1.29 1.07-
 
0.009 
1990 1.28 1.14-
 
<.001 1.18 0.86-1.62 0.30
 
1.60 1.30-
 
<.001 1.42 1.18-
 
<.001 
1991 1.29 1.15-
 
<.001 1.33 0.97-1.81 0.07
 
1.61 1.30-
 
<.001 1.40 1.16-
 
<.001 
1992 1.26 1.12-
 
<.001 1.25 0.92-1.71 0.16
 
1.55 1.25-
 
<.001 1.51 1.25-
 
<.001 
1993 1.26 1.13-
 
<.001 1.23 0.90-1.68 0.19
 
1.52 1.23-
 
<.001 1.44 1.19-
 
<.001 
1994 1.29 1.16-
 
<.001 1.22 0.89-1.67 0.21
 
1.67 1.36-
 
<.001 1.39 1.15-
 
<.001 
1995 1.29 1.16-
 
<.001 1.38 1.02-1.88 0.03
 
1.72 1.40-
 
<.001 1.23 1.01-
 
0.037 
1996 1.46 1.30-
 
<.001 1.63 1.22-2.19 0.00
 
1.71 1.40-
 
<.001 1.65 1.37-
 
<.001 
1997 1.32 1.18-
 
<.001 1.80 1.35-2.41 <.00
 
1.55 1.26-
 
<.001 1.25 1.03-
 
0.026 
1998 1.39 1.25-
 
<.001 1.34 0.99-1.82 0.05
 
1.85 1.51-
 
<.001 1.35 1.11-
 
0.002 
1999 1.44 1.29-
 
<.001 1.77 1.33-2.37 <.00
 
1.86 1.52-
 
<.001 1.51 1.25-
 
<.001 
2000 1.32 1.18-
 
<.001 1.70 1.27-2.27 <.00
 
1.65 1.34-
 
<.001 1.44 1.19-
 
<.001 
RR: Rate-ratio; p: p value; HNC: Head & neck cancer; OPC: Oropharyngeal cancer; OCC: Oral cavity cancer.  
    
 
Bold values represent statistical significance. 
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Table 3: Subgroup analysis- Adjusted Poisson regression rate-ratios for subsites by age, sex, geographic region, deprivation (SIMD 
2009), and year of diagnosis (2001-2012) 
  HNC   OPC  OCC  LARYX  
 RR 95% CI       p RR 95% CI     p RR 95% CI      p RR 95 % CI      p 
Age 
0-25 0.02 0.02-0.03 <0.001 0 0.00-0.01 <0.001 0.02 0.01-0.03 <0.001 0 0.00-0.01 <0.001 
26-30 0.07 0.05-0.10 <0.001 0.02 0.01-0.06 <0.001 0.09 0.06-0.14 <0.001 0.04 0.01-0.09 <0.001 
31-35 0.1 0.08-0.13 <0.001 0.05 0.02-0.08 <0.001 0.13 0.09-0.19 <0.001 0.05 0.02-0.10 <0.001 
36-40 0.24 0.20-0.28 <0.001 0.16 0.11-0.22 <0.001 0.25 0.19-0.33 <0.001 0.2 0.14-0.30 <0.001 
41-45 0.51 0.45-0.58 <0.001 0.47 0.37-0.58 <0.001 0.52 0.42-0.65 <0.001 0.44 0.33-0.59 <0.001 
46-50 (ref) 
 
-   -   -      51-55 2 1.83-2.20 <0.001 1.81 1.55-2.12 <0.001 1.82 1.55-2.14 <0.001 2.34 1.93-2.84 <0.001 
56-60 2.94 2.69-3.21 <0.001 2.23 1.91-2.61 <0.001 2.83 2.43-3.30 <0.001 4.08 3.40-4.89 <0.001 
61-65 3.6 3.30-3.92 <0.001 2.37 2.03-2.77 <0.001 3.51 3.02-4.07 <0.001 5.31 4.44-6.34 <0.001 
66-70 3.71 3.40-4.06 <0.001 2.01 1.70-2.38 <0.001 3.65 3.14-4.25 <0.001 6.35 5.31-7.59 <0.001 
71-75 3.81 3.48-4.18 <0.001 1.65 1.37-1.98 <0.001 3.7 3.17-4.33 <0.001 6.69 5.58-8.01 <0.001 
76-80 3.59 3.26-3.96 <0.001 1.66 1.36-2.03 <0.001 3.6 3.06-4.25 <0.001 6.17 5.10-7.46 <0.001 
81-85+ 3.35 3.00-3.73 <0.001 1 0.76-1.33 0.977 3.92 3.28-4.68 <0.001 4.73 3.80-5.89 <0.001 
Sex 
Male 2.81 2.70-2.92 <0.001 3.31 3.02-3.62 <0.001 1.82    1.71-
 
<0.001 4.6 4.24-5.00 <0.001 
Female(ref
 
 
-            
Region 
North (ref.) -   -   -   -   East 1.06 1.00-1.12 0.05 0.86 0.77-0.97 0.012 1.1 1.00-1.21 0.057 1.2 1.08-1.33 <0.001 
West 1.07 1.02-1.14 0.011 0.93 0.83-1.04 0.185 1.11 1.01-1.22 0.028 1.21 1.09-1.34 <0.001 
SIMD 
1 3.3 3.01-3.62 <0.001 3.33 2.72-4.07 <0.001 2.69 2.31-3.13 <0.001 4.98 4.15-5.97 <0.001 
2 2.6 2.37-2.85 <0.001 2.83 2.31-3.46 <0.001 2.08 1.78-2.43 <0.001 3.75 3.11-4.51 <0.001 
3 2.31 2.10-2.54 <0.001 2.33 1.89-2.86 <0.001 2 1.71-2.33 <0.001 3.19 2.64-3.84 <0.001 
4 1.89 1.72-2.08 <0.001 1.82 1.47-2.25 <0.001 1.62 1.38-1.90 <0.001 2.67 2.21-3.23 <0.001 
5 1.73 1.57-1.91 <0.001 1.74 1.41-2.16 <0.001 1.58 1.35-1.86 <0.001 2.13 1.75-2.60 <0.001 
6 1.58 1.43-1.75 <0.001 1.72 1.39-2.13 <0.001 1.44 1.22-1.69 <0.001 1.96 1.60-2.39 <0.001 
7 1.36 1.23-1.51 <0.001 1.61 1.30-2.00 <0.001 1.25 1.05-1.47   0.01 1.6 1.30-1.96 <0.001 
8 1.35 1.22-1.49 <0.001 1.6 1.29-1.99 <0.001 1.24 1.04-1.46   0.014 1.47 1.19-1.81 <0.001 
9 1.12 1.00-1.25   0.042 1.25 1.00-1.57   0.053 1.01 0.84-1.21   0.923 1.26 1.01-1.56 0.041 
10 (ref.) 
 
-   -   -   -   
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 Year 
2001 (ref.) -     -     -     -     
2002 0.97 0.88-1.07 0.52 0.98 0.78-1.23 0.864 1.05 0.89-1.23 0.586 0.91 0.77-1.07 0.235 
2003 1 0.91-1.10 0.977 1.05 0.84-1.31 0.667 1.11 0.94-1.30 0.216 0.91 0.78-1.07 0.252 
2004 1.01 0.92-1.10 0.906 1.17 0.94-1.45 0.163 1.03 0.88-1.21 0.689 0.95 0.81-1.11 0.516 
2005 0.97 0.88-1.06 0.516 1.15 0.93-1.43 0.198 1.05 0.90-1.23 0.53 0.85 0.73-1.00 0.054 
2006 1.01 0.92-1.11 0.798 1.2 0.97-1.48 0.101 1.01 0.86-1.18 0.944 0.95 0.81-1.11 0.516 
2007 1.03 0.91-1.13 0.478 1.25 1.01-1.54 0.039 1.12 0.95-1.31 0.169 0.88 0.75-1.04 0.126 
2008 0.97 0.88-1.06 0.464 1.24 1.00-1.53 0.046 1.05 0.89-1.23 0.571 0.83 0.70-0.97 0.021 
2009 1.08 0.99-1.18 0.101 1.6 1.31-1.95 <0.001 1.08 0.92-1.27 0.326 0.83 0.71-0.98 0.024 
2010 1.06 0.97-1.16 0.209 1.43 1.17-1.75 <0.001 1.08 0.93-1.27 0.317 0.89 0.76-1.04 0.155 
2011 1.04 0.95-1.13 0.442 1.48 1.21-1.81 <0.001 1.02 0.87-1.19 0.814 0.83 0.71-0.97 0.021 
2012 1.13 1.04-1.24 0.005 1.85 1.53-2.25 <0.001 1.1 0.94-1.28 0.242 0.77 0.65-0.90 0.001 
SIMD: Scottish index of multiple deprivation; RR: Rate-ratio; p: p value; HNC: Head & neck cancer; OPC: Oropharyngeal cancer; OCC: 
Oral cavity cancer. Bold values represent statistical significance. 
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